An Engineered Nanocomplex with Photodynamic and Photothermal Synergistic Properties for Cancer Treatment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Single-modality photodynamic therapy (PDT) and photothermal therapy (PTT) show limitations in cancer treatment success rates.
• Combined PDT and PTT protocols are gaining interest for enhanced therapeutic outcomes.

Purpose of the Study:

• To develop and evaluate a dual-action nanotherapeutic agent for combined PDT and PTT.
• To investigate the synergistic effects of combined PDT/PTT on SH-SY5Y human neuroblastoma cells.

Main Methods:

• Gold nanoparticles (AuNPs) were conjugated with the photosensitizer meso-tetrahydroxyphenylchlorin (mTHPC) to create AuNP-mTHPC nanotherapeutics.
• The nanotherapeutics were activated using 650-nm laser for PDT (ROS production) and 532-nm laser for PTT (photothermal conversion).
• Cell viability and mitochondrial membrane potential were assessed after treatment.

Main Results:

• The AuNP-mTHPC complex demonstrated biocompatibility, solubility, and photostability.
• PDT activation led to reactive oxygen species (ROS) production and decreased mitochondrial membrane potential.
• Combined PDT/PTT treatment resulted in a twofold increase in phototoxicity compared to single therapies, indicating synergistic effects.

Conclusions:

• The AuNP-mTHPC nanotherapeutic agent effectively combines PDT and PTT for enhanced cancer treatment.
• The synergistic action of combined PDT and PTT offers a promising strategy for cancer therapy in the biomedical field.